Artiva Biotherapeutics, Inc.
ARTV
$10.79
-$0.09-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 145.42% | -47.71% | -41.75% | -16.14% | 205.79% |
| Total Receivables | 39.90% | 156.41% | -26.67% | -37.26% | -34.02% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -74.59% | -64.33% | 80.39% | 124.12% | 247.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 136.32% | -47.80% | -40.27% | -13.97% | 199.64% |
|
|
|||||
| Total Current Assets | 136.32% | -47.80% | -40.27% | -13.97% | 199.64% |
| Net Property, Plant & Equipment | -23.90% | -21.60% | -15.03% | -14.18% | -12.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 154.51% | 93.88% | 75.05% | 58.09% | -85.44% |
| Total Assets | 117.62% | -44.60% | -37.52% | -34.01% | 123.14% |
|
|
|||||
| Total Accounts Payable | 14.07% | 12.28% | -68.33% | -30.21% | 47.63% |
| Total Accrued Expenses | 69.51% | -12.80% | 29.87% | -15.80% | -6.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.42% | -18.41% | -18.21% | -15.03% | -3.91% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 35.41% | -10.85% | 6.81% | -16.35% | -0.54% |
|
|
|||||
| Total Current Liabilities | 35.41% | -10.85% | 6.81% | -16.35% | -0.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.64% | -29.66% | -25.73% | -24.17% | -19.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.84% | -19.45% | -8.59% | -20.17% | -59.78% |
|
|
|||||
| Common Stock & APIC | 66.16% | 1.41% | 1.61% | 1.78% | 1,896.84% |
| Retained Earnings | -31.51% | -32.61% | -34.00% | -34.34% | -35.25% |
| Treasury Stock & Other | -1,150.00% | -- | 179.84% | -74.26% | -98.35% |
| Total Common Equity | 133.16% | -47.95% | -41.08% | -35.71% | 177.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 133.16% | -47.95% | -41.08% | -35.71% | 177.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 133.16% | -47.95% | -41.08% | -35.71% | 488.72% |
|
|
|||||